Public Health Archives - Page 18 of 36 - Boston Life Sciences Times

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

THIS WEEK'S STORIES

Response Pharmaceuticals Reports Positive Phase 2 Data for RDX-002 in Post-GLP-1 Weight Management

March 5, 2026

Thermo Fisher Scientific Opens Cryo-Electron Microscopy Drug Discovery Center in South San Francisco

March 5, 2026

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

March 10, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

AstraZeneca, Joshua Jackson Launch National Campaign Encouraging Cancer Screenings

Physicians Increasingly Concerned About Affordable Healthcare Access, athenahealth Survey Finds

Surescripts Reports Record Growth in Interoperability and Faster Prescription Access in 2025

Food Allergy Science Initiative Receives $10,000 Donation From Be Like Timmy Foundation After Valentine’s Day Event

RF Investment Partners Backs Recapitalization of Fire and Life Safety Provider NSG-Norel

Most Read

Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer

IFAW Urges Science-Based Conservation as Debate Over African Elephant Populations Intensifies

WHOOP Expands Health Platform with Women’s Blood Biomarker Panel and New Cycle Insights Tools

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

EDITOR PICKS

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

THIS WEEK'S STORIES

Response Pharmaceuticals Reports Positive Phase 2 Data for RDX-002 in Post-GLP-1 Weight Management

Thermo Fisher Scientific Opens Cryo-Electron Microscopy Drug Discovery Center in South San Francisco

Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board

POPULAR CATEGORY

ABOUT US

FOLLOW US